Drawing for XRS

USPTO serial 97244012

XRS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PETTICAN, NATHANIEL VINCIENT
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XRS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

B. Brett Heavner

B. Brett Heavner FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER LLP901 NEW YORK AVENUE NWWASHINGTON, DC 20001United States

Goods and services

ClassDescriptionStatusFirst use
001Biological tissue cultures other than for medical or veterinary purposes; cells for scientific, laboratory or medical researchACTIVE—
005Cells for medical or clinical use; biological tissue cultures for medical useACTIVE—
010Medical devices in the nature of an adjustable microscale encapsulation apparatus used to manipulate and study complex patient-derived cell tissue by measuring cell viability and drug response to aid in the development of personalized patient therapy and treatment of tumorsACTIVE—
042Pharmaceutical drug development and testing of anti-cancer drugsACTIVE—
044Medical testing for diagnostic purposes and medical treatment services in the field of oncologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 4, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 4, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 13, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 12, 2026EX5GSOU EXTENSION 5 GRANTED—
Feb 11, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 26, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 25, 2025EXT5SOU EXTENSION 5 FILED—
Mar 28, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 27, 2025EX4GSOU EXTENSION 4 GRANTED—
Mar 27, 2025EXT4SOU EXTENSION 4 FILED—
Mar 27, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 21, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 21, 2024EX3GSOU EXTENSION 3 GRANTED—
Jun 21, 2024EXT3SOU EXTENSION 3 FILED—
Jun 21, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 26, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 25, 2024EX2GSOU EXTENSION 2 GRANTED—
Mar 25, 2024EXT2SOU EXTENSION 2 FILED—
Mar 25, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 23, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 21, 2023EX1GSOU EXTENSION 1 GRANTED—
Sep 21, 2023EXT1SOU EXTENSION 1 FILED—
Sep 21, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 28, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 28, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 28, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 28, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 29, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 18, 2022GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 18, 2022GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Nov 18, 2022EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Nov 18, 2022CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Nov 9, 2022DOCKASSIGNED TO EXAMINER—
Feb 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 1, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance